Evidence map›Paper›PMID 20648236›Full record

ArticleDrug discovery today. Disease mechanisms2009

NR4A Orphan Nuclear Receptors in Cardiovascular Biology.

Yue Zhao, Dennis Bruemmer

Open access · greenAbstract read
In one paragraph

Article in Drug discovery today. Disease mechanisms, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 33 citations in OpenAlex.

  1. Senescence of T cells and organ aging.Inflammation and regeneration · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Enhanced CD25Scientific reports · 2017
    Article
  10. Article
  11. Selective ligand activity at Nur/retinoid X receptor complexes revealed by dimer-specific bioluminescence resonance energy transfer-based sensors.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2015
    Article
  12. Article
  13. NR4A nuclear receptors in immunity and atherosclerosis.Current opinion in lipidology · 2013
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yue ZhaoDivision of Endocrinology and Molecular Medicine, University of Kentucky College of Medicine, Lexington, KY 40536.
Dennis Bruemmer
University of Kentucky · US

Funding

Role of the Nuclear Receptor Nor-1 in Atherosclerosis and Vascular InjuryR01HL084611 · NHLBI · UNIVERSITY OF KENTUCKY · PI BRUEMMER, DENNIS CHRISTOPHER · 2006 to 2010
$2.1M
NHLBI NIH HHS R01 HL084611
6 · The paper itself

Abstract

The NR4A orphan nuclear receptor subfamily is comprised of the highly homologous receptors Nur77 (NR4A1), Nurr1 (NR4A2), and NOR1 (NR4A3). These evolutionarily conserved and ancient receptors function as ligand-independent transcription factors that regulate the expression of overlapping target genes. As early response genes, the basal expression level of these receptors is low but rapidly induced as a result of changes in environmental cues. The transcriptional activity of these receptors is primarily regulated by gene induction and posttranslational modifications of the receptor including phosphorylation. NR4A receptors were initially identified in the brain and early functional studies suggested a role for these receptors in signal- and cell-specific stimulation of both apoptosis and proliferation. More recent studies have revealed much broader functions of these orphan receptors including the regulation of genes involved in cancer, metabolism, energy balance, atherosclerosis, and vascular remodeling. In this review, we will discuss our current understanding of the molecular biology of NR4A receptors and summarize recent studies suggesting an important role of these orphan receptors in vascular biology.

Identifiers

PMID20648236
PMCPMC2905831
OpenAlexW1990740092

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.